Quick Answer
Oncology Institute, Inc. reported Revenue (ASC 606) of $502.73 million for fiscal year 2025.
Oncology Institute, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $502.73M | +27.8% |
| 2024 | $393.41M | +21.3% |
| 2023 | $324.24M | +28.4% |
| 2022 | $252.48M | +24.4% |
| 2021 | $203.00M | +8.3% |
| 2020 | $187.51M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $136.56M | +36.7% | +14.0% |
| June 30, 2025 | $119.80M | +21.5% | +14.7% |
| March 31, 2025 | $104.41M | +10.3% | +4.5% |
| September 30, 2024 | $99.90M | +21.8% | +1.3% |
| June 30, 2024 | $98.58M | +22.9% | +4.1% |
| March 31, 2024 | $94.67M | +24.2% | +15.4% |
| September 30, 2023 | $82.03M | +26.3% | +2.3% |
| June 30, 2023 | $80.22M | +31.7% | +5.3% |
- Oncology Institute, Inc. showed an increase of +27.8% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2020–2025 period, Oncology Institute, Inc.’s revenue (asc 606) has grown by 168.1% (from $187.51 million to $502.73 million).
- The most recent figure is from Oncology Institute, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: